Cystic fibrosis prenatal diagnosis: confirmation of an equivocal microvillar enzyme result by direct analysis of the common gene mutation.
A child was tentatively diagnosed as having cystic fibrosis, based on neonatal presentation with severe gastrointestinal complications; the diagnosis was not confirmed biochemically and no tissues were available for DNA analysis. The mother presented in her subsequent pregnancy, and microvillar enzyme analysis of cell-free amniotic fluid at both 18 and 20 weeks gestation gave equivocal results. The pregnancy was terminated voluntarily because of a trend towards abnormal enzyme assay results on the second amniocentesis. Retrospectively, fetal tissues were found to be homozygous for the most common mutation of the cystic fibrosis gene (delta F508), which confirmed the prenatal assessment and suggested that the first infant of the couple was probably also affected by the disease.
Carey
W F
WF
Department of Chemical Pathology, Adelaide Children's Hospital, South Australia.
Nelson
P V
PV
Raymond
S
S
Morris
C P
CP
D000469:Alkaline Phosphatase / Q000032:analysis; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000737:chemistry; D003550:Cystic Fibrosis / Q000175:diagnosis*; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D016133:Polymerase Chain Reaction; D011247:Pregnancy
D000469:Alkaline Phosphatase